Nektar Therapeutics (NKTR) Debt to Equity Ratio
Nektar Therapeutics (NKTR) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2015-12-31 | 76.56 |
| 2016-12-31 | 5.46 |
| 2017-12-31 | 4.79 |
| 2018-12-31 | 0.25 |
| 2019-12-31 | 0.41 |
| 2020-12-31 | 0.43 |
| 2021-12-31 | 0.64 |
| 2022-12-31 | 0.94 |
| 2023-12-31 | 2.04 |
| 2024-12-31 | 4.00 |
Get Nektar Therapeutics Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("NKTR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NKTR | $77.85 | +3.69% | 0.46M |
| 3 | ||||
| 4 | ||||
| 5 |